Sachem Capital Corp 800 Note (SCCG) reported QQ2 2024 revenue of $15.15 million with an exceptionally high gross margin near 99.37%, reflecting a structure with minimal direct cost of revenue. However, the quarter was marked by a substantial drag from operating and non-operating items, culminating in a net loss of $3.06 million and negative earnings per share of $0.064. Key drivers behind the quarterly pivot included elevated other expenses totaling $17.20 million and elevated operating expenses of $18.46 million, which overwhelmed the topline and gross margin, yielding a subdued bottom line despite positive EBITDA of $3.81 million and an operating income of $3.72 million. The quarter’s contingent items suggest non-recurring impairment or restructuring costs contributing to the unusual expense profile. On the balance sheet, liquidity remains robust on a trailing basis, with cash and short-term investments of about $12.38 million and a current ratio of approximately 104.4x. Total debt stands at $338.95 million against total assets of $586.32 million, yielding a capitalization structure that supports a debt-to-capitalization of 0.596 and a debt-to-equity ratio of 1.473. Cash flow from operations was positive at $6.96 million, but investing and financing activities produced a net cash outflow of $78.36 million, driving a negative net change in cash of roughly $7.84 million for the quarter. Near-term profitability remains a concern given ongoing non-operating costs and a negative quarterly net income; however, the company continues to exhibit a strong liquidity base and potential optionality from its short-term loan portfolio. Investors should monitor whether management can normalize non-operating costs, sustain operating cash flow, and achieve earnings growth through portfolio optimization and expense discipline.